PCPSA's 'No Harm' Standard Would Set High Bar For FDA Ingredient Review
This article was originally published in The Rose Sheet
Executive Summary
Regulatory consultants have concerns about the draft Personal Care Products Safety Act's proposed standard for FDA ingredient review – reasonable certainty of no harm. The standard's de facto application in FDA's review of new dietary ingredients in the supplement space has resulted in a fail rate of around 75%.